0
     

Report Added
Report already added
Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin market is projected to register a robust growth during the forecast period. The growth can be attributed to the rising number of patients suffering from diabetes and growing research & development activities for drug discovery. Insulin is used to manage blood sugar levels in the body and thus reduce the symptoms of diabetes and vascular complications. According to the World Health Organization statistics, Saudi Arabia ranks seventh in the rate of diabetes. The estimates show that 7 million of the country’s population are diabetic while 3 million have pre-diabetic conditions. Increasing awareness of diabetes and advancing healthcare facilities providing treatment for chronic disorders are also propelling the growth of Saudi Arabia human insulin market. The risk of diabetes is likely to increase with growing age, and currently around 25% adults over 60 years suffer from diabetes. Thus, increasing prevalence of geriatric population is also anticipated to fuel the growth of Saudi Arabia human insulin market in the coming years. Allocation of huge funds for the healthcare, launch of new programs to educate people about diabetics by the government, and technological advancements in the field of human insulin delivery devices are likely to drive the growth of Saudi Arabia human insulin market. However, stringent regulatory requirements for the product approvals as well high manufacturing costs could restrain the growth of Saudi Arabia human insulin market. Besides, the key players are making huge investments to devise effective ways to use insulin and minimize the side-effects, which is expected to contribute to the growth of Saudi Arabia human insulin market.

The Saudi Arabia Human Insulin market is segmented on the basis of indication, route of administration, type, onset time, products, regional distribution, and company. Based on the products, the market is divided into insulin pens, insulin pumps, infusion systems, and injection. The insulin pens segment is anticipated to dominate the Saudi Arabia human insulin market due to significant reimbursements offered for human insulin pens and their continuous pipeline development & product commercialization.

Key players in Saudi Arabia human insulin market are Novo Nordisk Saudi Arabia, Sanofi Saudi Arabia, Baxter International Saudi Arabia, B Braun Saudi Arabia, Eli Lilly and Company Saudi Arabia, Pfizer Saudi Arabia, among others. Companies involved in the Saudi Arabia human insulin market are adopting competitive strategies such as partnerships, agreements, awareness campaigns, and research funding & grants to strengthen their product portfolio and sustain growth in Saudi Arabia human insulin market.

Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F–2027F

Objective of the Study:
•To analyze the historical growth in the market size of Saudi Arabia human insulin market from 2017 to 2021.
•To estimate and forecast the market size of Saudi Arabia human insulin market from 2022E to 2027F and growth rate until 2027F.
•To classify and forecast Saudi Arabia human insulin market based on indication, route of administration, type, onset time, products, regional distribution, and company.
•To identify dominant region or segment in the Saudi Arabia human insulin market.
•To identify drivers and challenges for Saudi Arabia human insulin market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia human insulin market.
•To identify and analyze the profile of leading players operating in Saudi Arabia human insulin market.
•To identify key sustainable strategies adopted by market players in Saudi Arabia human insulin market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the Saudi Arabia. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the Saudi Arabia.

TechSci Research calculated the market size of Saudi Arabia human insulin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Human insulin developing companies
•Market research and consulting firms
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances related to human insulin
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, Saudi Arabia Human Insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Saudi Arabia Human Insulin Market, By Indication:
oType I Diabetes
oType II Diabetes
•Saudi Arabia Human Insulin Market, By Route of Administration:
oSubcutaneous
oNasal
oIntravenous
oTransdermal
oOral
oOthers
•Saudi Arabia Human Insulin Market, By Type:
oBasal
oBolus
oPre-mixed
oBiosimilar
oTraditional
•Saudi Arabia Human Insulin Market, By Onset Time:
oRapid Acting
oShort-Acting
oIntermediate Acting
oLong Acting
oUltra-long Acting
oPre-Mixed
oInhaled
•Saudi Arabia Human Insulin Market, By Products:
oInsulin Pens
oInsulin Pumps
oInfusion System
oInjection
•Saudi Arabia Human Insulin Market, By Region:
oNorthern & Central
oSouthern
oEastern
oWestern
Competitive Landscape

Company Profiles:Detailed analysis of the major companies present in Saudi Arabia Human Insulin market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Voice of Customer
5.Impact of COVID-19 on Saudi Arabia Human Insulin Market
6.Saudi Arabia Human Insulin Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Indication (Type I Diabetes, Type II Diabetes)
6.2.2.By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal,
Oral and Others)
6.2.3.By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
6.2.4.By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)
6.2.5.By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)
6.2.6.By Company (2021)
6.2.7.By Region
6.3.Product Market Map
7.Northern & Central Saudi Arabia Human Insulin Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Indication
7.2.2.By Route of Administration
7.2.3.By Type
7.2.4.By Onset Time
7.2.5.By Products
8.Southern Saudi Arabia Human Insulin Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Indication
8.2.2.By Route of Administration
8.2.3.By Type
8.2.4.By Onset Time
8.2.5.By Products
9.Eastern Saudi Arabia Human Insulin Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Indication
9.2.2.By Route of Administration
9.2.3.By Type
9.2.4.By Onset Time
9.2.5.By Products
10.Western Saudi Arabia Human Insulin Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Indication
10.2.2.By Route of Administration
10.2.3.By Type
10.2.4.By Onset Time
10.2.5.By Products
11.Market Dynamics
11.1.Drivers
11.2.Challenges
12.Market Trends & Developments
13.Policy & Regulatory Landscape
14.Saudi Arabia Economic Profile
15.Competitive Landscape
15.1.Competition Outlook
15.2.Company Profiles
15.2.1.Novo Nordisk Saudi Arabia
15.2.2.Sanofi Saudi Arabia
15.2.3.Baxter International Saudi Arabia
15.2.4.B Braun Saudi Arabia
15.2.5.Eli Lilly and Company Saudi Arabia
15.2.6.Pfizer Saudi Arabia
16.Strategic Recommendations

Report Title: Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

Related Report

2022 Saudi Arabia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

2022 Saudi Arabia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests


2022-2026 Saudi Arabia Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022-2026 Saudi Arabia Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM


Saudi Arabia Veterinary Medicine Market, By Animal Type (Production {Poultry, Sheep & Goats, Cattle, Others} v/s Companion {Cats, Horses, Dogs, Others}), By Product Type (Pharmaceuticals {Parasiticides, Analgesics, Anti-Inflammatory, Anti-infectives, Others}, Vaccine {Inactive Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others},  Medicated Feed Additives {Amino acids, Antibiotics, Others}), By End User (Veterinary clinics,  Veterinary Hospitals, Others), By Source (Import v/s Domestic), By Region, Competition Forecast & Opportunities, 2017-2027

Saudi Arabia Veterinary Medicine Market, By Animal Type (Production {Poultry, Sheep & Goats, Cattle, Others} v/s Companion {Cats, Horses, Dogs, Others}), By Product Type (Pharmaceuticals {Parasiticides, Analgesics, Anti-Inflammatory, Anti-infectives, Others}, Vaccine {Inactive Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others}, Medicated Feed Additives {Amino acids, Antibiotics, Others}), By End User (Veterinary clinics, Veterinary Hospitals, Others), By Source (Import v/s Domestic), By Region, Competition Forecast & Opportunities, 2017-2027


2022 Saudi Arabia Immunodiagnostic Market Database, Shares and Forecasts for Over 100 Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers: Growth Opportunities, Supplier Strategies, Emerging Technologies, Latest Instrumentation

2022 Saudi Arabia Immunodiagnostic Market Database, Shares and Forecasts for Over 100 Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers: Growth Opportunities, Supplier Strategies, Emerging Technologies, Latest Instrumentation


2022-2026 Saudi Arabia Clinical Chemistry Market Database--Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests

2022-2026 Saudi Arabia Clinical Chemistry Market Database--Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests


2022 Saudi Arabia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline Review

2022 Saudi Arabia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline Review


SELECT A FORMAT

ADD TO CART BUY NOW